Keyphrases
ABCG2
100%
Activated Cells
100%
Activated Surface
9%
Adoptive Immunotherapy
18%
Cancer Patients
18%
CD27
27%
CD28
18%
CD3+CD56+ Cells
9%
CD4+
18%
CD8+
18%
Cell Surface Markers
100%
Cell-derived
100%
Cord Blood
100%
Cord Blood Mononuclear Cells
9%
Cytokine-induced Killer Cells
100%
Density Gradient
9%
Differential Expression
9%
Drug Resistance Gene
100%
Ficoll
9%
Flow Cytometry
9%
High-level Expression
9%
Immunophenotyping
9%
In Cancer
18%
Incubation
9%
Inhibitory Cells
18%
Low Expression
9%
Mononuclear Cells
9%
Nanog
18%
No Significant Difference
9%
Octamer-binding Transcription Factor 4 (OCT4)
9%
Peripheral Blood
63%
Plaque Density
9%
Programmed Death-ligand 1 (PD-L1)
18%
Proliferation Index
9%
Proliferation Rate
9%
Quantitative PCR
9%
Sex-determining Region Y-box 2 (SOX2)
18%
Stem Cell Factor
27%
Surface Low
9%
Surface Marker Expression
9%
Surface Markers
9%
Transcription Factor c-Myc
18%
Tumor
9%
Umbilical Cord Blood
100%
Immunology and Microbiology
ABCG2
100%
CD28
50%
CD3 Antigen
25%
CD4
50%
CD8
50%
Cell Surface Marker
100%
Cytokine
25%
Cytokine Induced Killer Cell
100%
Density Gradient
25%
Drug Resistance
100%
Immunotherapy
50%
Mononuclear Cell
50%
Oncogene C Myc
50%
Reverse Transcription Polymerase Chain Reaction
25%
Stem Cell
75%
Transcription Factors
75%
Umbilical Cord Blood
100%
Neuroscience
Breast Cancer Resistance Protein
100%
CD27
75%
CD28
50%
CD3 Antigen
25%
CD4
50%
CD8
50%
Drug Resistance
100%
Flow Cytometry
25%
Immunophenotyping
25%
Immunotherapy
50%
In Vitro
25%
Oncogene C Myc
50%
Stem Cell
75%
Transcription Factors
75%
Medicine and Dentistry
Breast Cancer Resistance Protein
100%
CD3 Antigen
7%
CD8 Antigen
15%
Cell Surface Marker
100%
Cord Blood
100%
Cytokine
7%
Cytokine Induced Killer Cell
100%
Drug Resistance
100%
Ficoll
7%
Flow Cytometry
7%
Immunophenotyping
7%
Immunotherapy
15%
In Vitro
7%
Incubation
7%
Malignant Neoplasm
15%
Mononuclear Cell
15%
Neoplasm
7%
Oncogene C Myc
15%
Reverse Transcription Polymerase Chain Reaction
7%
Stem Cell
23%
Transcription Factors
23%